Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.19.8451

Association between Cigarette Smoking and RASSF1A Gene Promoter Hypermethylation in Lung Cancer Patients: a Meta-analysis  

Wu, Xiao-Ming (Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology)
Chen, Yu (Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology)
Shao, Yang (Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology)
Zhou, Xiao-Long (Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology)
Tang, Wen-Ru (Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.19, 2014 , pp. 8451-8454 More about this Journal
Abstract
Objectives: Epidemiological studies have shown that molecular mechanisms underlying the development of lung cancers differ between smokers and unsmokers. Aberrant promoter methylation in some tumor suppressor genes is frequent in lung tumors from smokers but rare in those from non-smokers. Recently, many studies have investigated the association between cigarette smoking and RASSF1A gene promoter hypermethylation in lung cancer patients, but a unanimous conclusion could not be reached. We therefore performed this meta-analysis to derive a more precise estimation of any association. Study Design: An electronic search of PubMed and Chinese Biomedicine databases was conducted to select studies. A total of 19 case-control studies were chosen, and odds ratios (ORs) with confidence intervals (CIs) were used to assess the strength of associations. Results: The case-control studies covered 2, 287 lung cancer patients: 63.4%(1449) of the patients were smokers, 36.6% (838) were unsmokers. The overall results suggested that smokers with lung cancer had a 1.297-fold (95% CI: 1.066~1.580, p=0.010, p=0.087) higher risk for RASSF1A gene hypermethylation than the non-smokers. In the stratified analysis, an increased risk of RASSF1A gene hypermethylation in smokers than in non-smokers was found in Asian (OR=1.481, 95%CI: 1.179~1.861, p=0.001, p=0.186). Conclusions: This meta-analysis supports the idea that RASSF1A gene hypermethylation is associated with cigarette smoking-induced lung cancer.
Keywords
Cigarette smoking; RASSF1A hypermethylation; meta-analysis; lung cancer;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Burbee DG, Forgacs E, Zochbauer-Muller S, et al (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst, 93, 691-9.   DOI   ScienceOn
2 Dammann R, Li C, Yoon JH, et al (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 25, 315-9.   DOI   ScienceOn
3 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
4 Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
5 Endoh H, Yatabe Y, Shimizu S, et al (2003). RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer, 106, 45-51.   DOI
6 Ge YZ, Xu LW, Jia RP, et al (2014). The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Tumour Biol, 35, 3881-90.   DOI   ScienceOn
7 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
8 Grote HJ, Schmiemann V, Geddert H, et al (2006). Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Cancer, 108, 129-34.   DOI   ScienceOn
9 Hesson LB, Cooper WN, Latif F (2007). The role of RASSF1A methylation in cancer. Dis Markers, 23, 73-87.   DOI
10 Honorio S, Agathanggelou A, Schuermann M, et al (2003). Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Oncogene, 22, 147-50.   DOI   ScienceOn
11 Khokhlatchev A, Rabizadeh S, Xavier R, et al (2002). Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol, 12, 253-65.   DOI   ScienceOn
12 Kim DH, Kim JS, Ji YI, et al (2003). Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res, 63, 3743-6.
13 Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a metaanalysis of published data. Asian Pac J Cancer Prev, 14, 3719-24.   DOI   ScienceOn
14 Lin RK, Hsieh YS, Lin P, et al (2010). The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest, 120, 521-32.   DOI
15 Lin RK, Hsu HS, Chang JW, et al (2007). Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer, 55, 205-13.   DOI
16 Liu L, Tommasi S, Lee DH, et al (2003). Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene, 22, 8125-36.   DOI
17 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
18 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
19 Mathe E (2004). RASSF1A, the new guardian of mitosis. Nat Genet, 36, 117-8.   DOI
20 Shivakumar L, Minna J, Sakamaki T, et al (2002). The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol, 22, 4309-18.   DOI   ScienceOn
21 Tomizawa Y, Kohno T, Kondo H, et al (2002). Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res, 8, 2362-8.
22 Villeneuve PJ, Mao Y (1994). Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health, 85, 385-8.
23 Zochbauer-Muller S, Fong KM, Virmani AK, et al (2001). Aberrant promoter methylation of multiple genes in nonsmall cell lung cancers. Cancer Res, 61, 249-55.
24 Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.   DOI   ScienceOn
25 Wang SH, Liu NH, Wang J, et al (2008). Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer. Chin Med J (Engl), 121, 1712-21.